Selenomethionine liver scanning in the diagnosis of hepatoma
- 1 June 1980
- journal article
- research article
- Published by Oxford University Press (OUP) in The British Journal of Radiology
- Vol. 53 (630) , 538-543
- https://doi.org/10.1259/0007-1285-53-630-538
Abstract
Liver subtraction scans using 99Tcm sulphur colloid and 75Se-selenomethionine were conducted in 58 patients with suspected hepatoma. Of the 18 patients with hepatoma proven by histology, 16 showed selective concentration of selenomethionine in the tumor, giving a true positive rate of 89%. Of the 40 patients did not have hepatoma, 32 scans showed no evidence of selective concentration of selenomethionine, giving a true negative rate of 80%. The false positive rate was 8% in non-cirrhotic patients with focal disease, but 55% in patients with cirrhosis. Combined scanning with this technique apparently is, useful in non-cirrhotic patients in distinguishing hepatoma from other causes of focal disease; the technique is not useful and frequently misleading in patients with cirrhosis.This publication has 5 references indexed in Scilit:
- INDUCTION OF REMISSION IN HEPATOCELLULAR CARCINOMA WITH DOXORUBICINThe Lancet, 1978
- Detection of hepatoma in liver cirrhosisEuropean Journal of Nuclear Medicine and Molecular Imaging, 1977
- Increased Specificity of Liver Scanning with the Use of67Gallium CitrateNew England Journal of Medicine, 1972
- 75Se-selenomethionine in hepatic focal lesionsSeminars in Nuclear Medicine, 1972
- 75Se-selenomethionine in the scintiscan diagnosis of primary hepatocellular carcinomaGut, 1971